Arrow International midline and central venous catheter kits recalled for contaminated anesthetic and saline components
Arrow International catheter kits recalled for contaminated anesthetic
Arrow International catheter kits contain lidocaine, bupivacaine, and saline solution from a supplier with quality control issues. The supplier's products may not be sterile or effective. If these injectable components are contaminated, they could cause serious or life-threatening infections.
- Stop using affected catheter kits immediately if you have one in your facility.
- Check the product lot numbers on your kits against the recalled batches.
- Contact Arrow International or your supplier for instructions on returning or replacing affected kits.
- Report any patient injuries or product issues to the FDA MedWatch program.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2394-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief